Design, synthesis and biological evaluation of a novel library of antimitotic C2-aroyl/arylimino tryptamine derivatives that are also potent inhibitors of indoleamine-2, 3-dioxygenase (IDO).

A novel library of C2-substituted tryptamines (based on diverse C2-aroyl/arylimino indoles and indole-diketopiperazine hybrids) possessing antimitotic properties were designed, synthesized and screened for their inhibitory activity against tubulin polymerization, and against proliferation of A549 lung cancer, HeLa cervical cancer, MCF7 breast cancer and HePG2 liver cancer cell lines. The design of molecules were inspired from known antimitotic compounds and natural products. The molecular docking of the designed compounds indicated that they bind to the colchicin binding site of tubulin. They were synthesized by a unique iodine catalysed oxidative ring opening reaction of 1-aryltetrahydro-ß-carbolines. Among the compounds synthesized quite a few compounds induced cytotoxicity on the cancer cells by disrupting the tubulin polymerization. They were found to be non-toxic for healthy cells. Immuno Fluorescence study for the most active molecules (between ~6 µM concentration) against A549 and HeLa cells demonstrated complete disruption and shrinkage of the microtubule structures. These compounds also inhibited indoleamine-2, 3-dioxygenase with low micromolar IC50.

Purity Evaluation of Curcuminoids in the Turmeric Extract Obtained by Accelerated Solvent Extraction.

Curcuminoids, the active principle of Curcuma longa L, is one of the most researched subjects worldwide for its broad-spectrum biological activities. Being traditionally known for their anticancer properties and issues related to bioavailability, the curcuminoids, including diferuloylmethane (curcumin), have gained special attention. Thus, the current study focused on the purity profiling of curcuminoids when extracted by accelerated solvent extraction, which was run with turmeric rhizome powder (20 g) at 1500 psi and at 50°C, with a static time of 10 min and with three cycles. The performance of ethanol, ethyl acetate, and acetone as extraction solvents was comparatively evaluated. Once extracted, the individual curcuminoids (curcumin, demethoxycurcumin, and bisdemethoxycurcumin) were purified by column chromatography, followed by preparative TLC, and the compounds were characterized by spectroscopic and chromatographic techniques. The HPLC method was standardized by using a gradient mobile phase of water and acetonitrile containing 0.1% formic acid. The LODs were calculated as 0.27, 0.33, and 0.42 µg/mL for curcumin, demethoxycurcumin, and bisdemethoxycurcumin, respectively. Accuracy (relative percentage error) and precision RSD values of the developed HPLC method were below 5%. The intraday accuracy ranged between -0.9 and -3.63%. The physical yield was the highest in ethanol (8.4%) extraction, followed by ethyl acetate (7.4%) and acetone (6.6%). Maximum purity was recorded in acetone (46.2%), followed by ethanol (43.4%) and ethyl acetate (38.8%), with no significant differences across the individual curcuminoids. This research will be useful for future applications related to the extraction of curcuminoids at a commercial level and to their profiling in food matrixes.

Estrogenic activity of a hydro-alcoholic extract of Bambusa arundinaceae leaves on female wistar rats.

To study the estrogenic activity of the hydro-alcoholic extract of Bambusa arundinaceae leaves (HEBA) in female Wistar rats. The dried powdered leaves were extracted with hydroalcoholic mixture (60%), and the resultant extract was subjected for phytochemical analyses to identify different phytoconstituents. HEBA were administered to ovariectomized rats for 7 days at three different doses (viz., 200, 300, 400 mg/kg body weight, p.o.) and their estrogenic activity were compared with each of daily treatment with 0.2 mg/kg body weight, i.p. conjugated equine estrogen as a positive control or olive oil as a negative control. Estrogenic activity was evaluated by doing uterotropic assay, vaginal cytology and measurement of vaginal opening in female Wistar rats. Oral administration of HEBA in ovariectomized immature and mature female Wistar rats in a dose of 400 mg/kg b.w. resulted in significant increase in the uterine wet weight (in mg) (224.82 ± 7.01) and (912.25 ± 27.22) when compared with ovariectomized control rats (111.52 ± 3.17) and (506.67 ± 21.39). HEBA (400 mg/kg b.w., p.o.) treated rats, showing only cornified epithelial cells which was an indication of the presence of the estrogen and also showed 100% vaginal opening. It was observed that HEBA possess significant estrogenic activity at 400 mg/kg b.w., p.o. which was evident by uterotropic assay, measurement of vaginal opening, and histopathological changes.